Cargando…

Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis

INTRODUCTION: Characterizing neuroanatomical markers of different stages of schizophrenia (SZ) to assess of how the disorder develops is extremely important for the clinical practice. It still remains uncertain how abnormalities are formed as SZ progresses. OBJECTIVES: We reviewed and analyzed 113 v...

Descripción completa

Detalles Bibliográficos
Autores principales: Brasso, C., Liloia, D., Cauda, F., Mancuso, L., Nani, A., Manuello, J., Costa, T., Duca, S., Rocca, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470480/
http://dx.doi.org/10.1192/j.eurpsy.2021.360
_version_ 1784788854669049856
author Brasso, C.
Liloia, D.
Cauda, F.
Mancuso, L.
Nani, A.
Manuello, J.
Costa, T.
Duca, S.
Rocca, P.
author_facet Brasso, C.
Liloia, D.
Cauda, F.
Mancuso, L.
Nani, A.
Manuello, J.
Costa, T.
Duca, S.
Rocca, P.
author_sort Brasso, C.
collection PubMed
description INTRODUCTION: Characterizing neuroanatomical markers of different stages of schizophrenia (SZ) to assess of how the disorder develops is extremely important for the clinical practice. It still remains uncertain how abnormalities are formed as SZ progresses. OBJECTIVES: We reviewed and analyzed 113 voxel based morphometry studies on people at risk of or with schizophrenia to assess GM alterations at different stages of the disorder and to functionally characterize these GM variations. METHODS: We performed a meta-analysis of voxel-based morphometry studies of genetic and clinical high-risk subjects (g-/c-HR), recently diagnosed (RDSZ) and chronic SZ patients (ChSZ). We quantified gray matter (GM) changes associated with these four conditions and compared them with contrast and conjunctional data. We performed the behavioral analysis and networks decomposition of alterations to obtain their functional characterization. RESULTS: Compared to previous investigations, results reveal a robust cortical-subcortical, left-to-right homotopic progression of GM loss. The right anterior cingulate is the only altered region in all conditions. Contrast analyses show left-lateralized insular, amygdalar and parahippocampal GM reduction in RDSZ, which appears bilateral in ChSZ. An overlap between RDSZ and ChSZ is observed in the left insula, amygdala, precentral and inferior frontal gyri. Functional decomposition shows involvement of the salience network, with an enlargement of the sensorimotor network in RDSZ and the thalamus-basal nuclei network in ChSZ. [Figure: see text] CONCLUSIONS: These results can help the research on diagnostic and neuroimaging biomarkers of SZ staging, as well as on the identification of new therapeutics neuroanotomic targets that could be addressed with focused magnetic or non-invasive electric stimulation. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9470480
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94704802022-09-29 Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis Brasso, C. Liloia, D. Cauda, F. Mancuso, L. Nani, A. Manuello, J. Costa, T. Duca, S. Rocca, P. Eur Psychiatry Abstract INTRODUCTION: Characterizing neuroanatomical markers of different stages of schizophrenia (SZ) to assess of how the disorder develops is extremely important for the clinical practice. It still remains uncertain how abnormalities are formed as SZ progresses. OBJECTIVES: We reviewed and analyzed 113 voxel based morphometry studies on people at risk of or with schizophrenia to assess GM alterations at different stages of the disorder and to functionally characterize these GM variations. METHODS: We performed a meta-analysis of voxel-based morphometry studies of genetic and clinical high-risk subjects (g-/c-HR), recently diagnosed (RDSZ) and chronic SZ patients (ChSZ). We quantified gray matter (GM) changes associated with these four conditions and compared them with contrast and conjunctional data. We performed the behavioral analysis and networks decomposition of alterations to obtain their functional characterization. RESULTS: Compared to previous investigations, results reveal a robust cortical-subcortical, left-to-right homotopic progression of GM loss. The right anterior cingulate is the only altered region in all conditions. Contrast analyses show left-lateralized insular, amygdalar and parahippocampal GM reduction in RDSZ, which appears bilateral in ChSZ. An overlap between RDSZ and ChSZ is observed in the left insula, amygdala, precentral and inferior frontal gyri. Functional decomposition shows involvement of the salience network, with an enlargement of the sensorimotor network in RDSZ and the thalamus-basal nuclei network in ChSZ. [Figure: see text] CONCLUSIONS: These results can help the research on diagnostic and neuroimaging biomarkers of SZ staging, as well as on the identification of new therapeutics neuroanotomic targets that could be addressed with focused magnetic or non-invasive electric stimulation. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470480/ http://dx.doi.org/10.1192/j.eurpsy.2021.360 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Brasso, C.
Liloia, D.
Cauda, F.
Mancuso, L.
Nani, A.
Manuello, J.
Costa, T.
Duca, S.
Rocca, P.
Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
title Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
title_full Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
title_fullStr Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
title_full_unstemmed Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
title_short Gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
title_sort gray matter reduction in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: a revised coordinate-based meta-analysis
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470480/
http://dx.doi.org/10.1192/j.eurpsy.2021.360
work_keys_str_mv AT brassoc graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT liloiad graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT caudaf graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT mancusol graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT nania graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT manuelloj graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT costat graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT ducas graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis
AT roccap graymatterreductioninhighrisksubjectsrecentlydiagnosedandchronicpatientswithschizophreniaarevisedcoordinatebasedmetaanalysis